Figure 1 (Lanthanum 01)
Lanthanum Carbonate Tablet, Chewable
Product Images NDC 76282-476
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lanthanum Carbonate (NDC 76282-476). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (500 mg Tablet Bottle Package)
This text seems to be a combination of several short pieces of information about a medication called Lanthanum Carbonate chewable tablets. The text gives instructions on how to take the medication and whom to ask for advice. It also includes some information for pharmacists and details about the packaging and dosage of the tablets.*
Principal Display Panel (750 mg Tablet Bottle Package)
This is a label for a medication called Lanthanum Carbonate, which is in chewable tablet form. The label provides dosage instructions, indicating that the tablets can be chewed or crushed before swallowing. It also contains information for patients, advising them to contact their doctor for further instructions. The label also includes a warning about potential kidney complications.*
Principal Display Panel (1000 mg Tablet Bottle Package)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
